Cosmo Appoints Federico Sommariva as Chief Legal Counsel
Cosmo Pharmaceuticals (SIX: COPN, FSE: C43) has announced the appointment of Federico Sommariva as Chief Legal Counsel, reporting directly to the CEO and joining the management team. Sommariva brings extensive legal and management experience from the Lifesciences industry, most recently serving as Director and Global Legal Business Partner Oncology at Gilead Sciences in Milan since 2013. He also held the position of interim Head of Legal and Compliance for Gilead Sciences Romania for 1.5 years.
Sommariva, a University of Milan law graduate, began his career as Legal Counsel Secondee at H&M in Rome. CEO Giovanni Di Napoli expressed confidence that Sommariva's expertise in corporate law and industry knowledge will support the company's long-term growth and help navigate the evolving regulatory landscape.
Cosmo Pharmaceuticals (SIX: COPN, FSE: C43) ha annunciato la nomina di Federico Sommariva come Chief Legal Counsel, riportando direttamente al CEO e unendosi al team di gestione. Sommariva porta con sé una vasta esperienza legale e gestionale nel settore delle scienze della vita, avendo ricoperto recentemente il ruolo di Direttore e Global Legal Business Partner Oncology presso Gilead Sciences a Milano dal 2013. Ha anche ricoperto la posizione di Head of Legal e Compliance ad interim per Gilead Sciences Romania per 1,5 anni.
Sommariva, laureato in giurisprudenza all'Università di Milano, ha iniziato la sua carriera come Legal Counsel Secondee presso H&M a Roma. Il CEO Giovanni Di Napoli ha espresso fiducia nel fatto che l'expertise di Sommariva in diritto societario e la sua conoscenza del settore supporteranno la crescita a lungo termine dell'azienda e aiuteranno a navigare nel panorama normativo in evoluzione.
Cosmo Pharmaceuticals (SIX: COPN, FSE: C43) ha anunciado el nombramiento de Federico Sommariva como Consejero Legal Principal, reportando directamente al CEO y uniéndose al equipo de gestión. Sommariva aporta una amplia experiencia legal y de gestión en la industria de las ciencias de la vida, habiendo ocupado recientemente el cargo de Director y Socio Legal Global de Oncología en Gilead Sciences en Milán desde 2013. También ocupó el puesto de Jefe de Legal y Cumplimiento interino para Gilead Sciences Rumania durante 1,5 años.
Sommariva, graduado en derecho por la Universidad de Milán, comenzó su carrera como Consejero Legal Secondee en H&M en Roma. El CEO Giovanni Di Napoli expresó su confianza en que la experiencia de Sommariva en derecho corporativo y su conocimiento de la industria apoyarán el crecimiento a largo plazo de la empresa y ayudarán a navegar el panorama regulatorio en evolución.
코스모 제약 (SIX: COPN, FSE: C43)는 페데리코 소마리바를 최고 법률 고문으로 임명했다고 발표했으며, CEO에게 직접 보고하고 경영 팀에 합류합니다. 소마리바는 생명 과학 산업에서 폭넓은 법률 및 관리 경험을 가지고 있으며, 최근에는 2013년부터 밀라노의 길리어드 사이언스에서 종양학 글로벌 법률 비즈니스 파트너로 재직했습니다. 그는 또한 길리어드 사이언스 루마니아의 법률 및 준수 책임자 직무를 1.5년 동안 맡았습니다.
밀라노 대학교 법학 졸업생인 소마리바는 로마의 H&M에서 법률 고문 세컨디로 경력을 시작했습니다. CEO 조반니 디 나폴리는 소마리바의 기업 법률 전문 지식과 산업 지식이 회사의 장기적인 성장에 기여하고 변화하는 규제 환경을 탐색하는 데 도움이 될 것이라고 확신했습니다.
Cosmo Pharmaceuticals (SIX: COPN, FSE: C43) a annoncé la nomination de Federico Sommariva en tant que Conseiller Juridique Principal, rapportant directement au PDG et rejoignant l'équipe de direction. Sommariva apporte une vaste expérience juridique et managériale dans le secteur des sciences de la vie, ayant récemment occupé le poste de Directeur et Partenaire Légal Global en Oncologie chez Gilead Sciences à Milan depuis 2013. Il a également été responsable par intérim du département juridique et de la conformité pour Gilead Sciences Roumanie pendant 1,5 an.
Sommariva, diplômé en droit de l'Université de Milan, a commencé sa carrière en tant que Conseiller Juridique Secondee chez H&M à Rome. Le PDG Giovanni Di Napoli a exprimé sa confiance dans le fait que l'expertise de Sommariva en droit des affaires et sa connaissance du secteur soutiendront la croissance à long terme de l'entreprise et aideront à naviguer dans le paysage réglementaire en évolution.
Cosmo Pharmaceuticals (SIX: COPN, FSE: C43) hat die Ernennung von Federico Sommariva zum Chief Legal Counsel bekannt gegeben, der direkt an den CEO berichtet und dem Management-Team beitritt. Sommariva bringt umfangreiche rechtliche und managementtechnische Erfahrung aus der Life-Sciences-Branche mit, zuletzt als Direktor und Global Legal Business Partner Oncology bei Gilead Sciences in Mailand seit 2013 tätig. Er hatte auch die Position des interimistischen Leiters für Recht und Compliance bei Gilead Sciences Rumänien für 1,5 Jahre inne.
Sommariva, Absolvent der Juristischen Fakultät der Universität Mailand, begann seine Karriere als Legal Counsel Secondee bei H&M in Rom. CEO Giovanni Di Napoli äußerte das Vertrauen, dass Sommarivas Expertise im Unternehmensrecht und Branchenwissen das langfristige Wachstum des Unternehmens unterstützen und helfen wird, sich im sich wandelnden regulatorischen Umfeld zurechtzufinden.
- Strengthened legal leadership with experienced industry professional
- Addition of executive with global pharmaceutical industry expertise
- Enhanced regulatory compliance capabilities through new appointment
- None.
Dublin, Ireland--(Newsfile Corp. - April 1, 2025) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) today announced the appointment of Federico Sommariva ad Chief Legal Counsel. Federico reports to the CEO and is member of the management team.
Federico Sommariva has many years of legal and management experience in the Lifesciences industry. Since June 2013, he has worked for Gilead Sciences based in Milan (Italy), with increasing responsibilities. Most recently, he acted as Director and Global Legal Business Partner Oncology. He also served for 1.5 years as interim Head of Legal and Compliance for Gilead Sciences Romania. Federico studied law at the University of Milan and started his professional career as Legal Counsel Secondee at H&M in Rome (Italy).
Giovanni Di Napoli, CEO of Cosmo, commented: “We are delighted to welcome Federico as our new Chief Legal Counsel. With his expertise in corporate law and industry knowledge, he will play a crucial role in guiding our Company through an evolving regulatory landscape and supporting our long-term growth. Federico’s proven track record and commitment make him an invaluable addition to our leadership team.”
Federico Sommariva, Chief Legal Counsel, added: “I am honored to join Cosmo as Chief Legal Counsel and look forward to contributing to its continued success. Cosmo has built a strong reputation for innovation and excellence, and I look forward to working with the management team to navigate the legal and regulatory landscape, thus supporting the Company’s strategic ambitions and objectives.”
About Cosmo
Cosmo Pharmaceuticals N.V. is committed to revolutionizing healthcare and transforming people’s lives by researching and developing innovative products that tackle unfulfilled healthcare demands. As a pharmaceutical company, Cosmo is active in the areas of Healthtech/AI, dermatology, gastroenterology and contract manufacturing & development. For the commercialization and distribution of its products, Cosmo collaborates with leading partners worldwide, including Medtronic and Sun Pharma. Founded in 1997, Cosmo is headquartered in Dublin (Ireland) and has offices also in San Diego (USA), and Lainate/Rome/Catania (Italy). The Company has approximately 330 employees at the end of 2024, all dedicated to making a significant impact in the field of healthcare. For more information, please visit www.cosmopharma.com.
Upcoming Events
| Life Sciences Conference, Amsterdam Ordinary Annual General Meeting of Shareholders Investor Day, Zurich | April 2-3, 2025 May 30, 2025 July 1, 2025 |
| 2025 Half-Year Results and Report | July 23, 2025 |
For further information, please contact:
Attachments
250401_Cosmo Pharma_Media Release_Chief Legal Counsel_EN_final
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/246892
FAQ
What is Federico Sommariva's background before joining Cosmo Pharmaceuticals (CMOPF)?
What role will Federico Sommariva have at Cosmo Pharmaceuticals (CMOPF)?
When does Federico Sommariva start as Chief Legal Counsel at Cosmo Pharmaceuticals (CMOPF)?
What are Federico Sommariva's responsibilities at Cosmo Pharmaceuticals (CMOPF)?
